Pharmacotherapy of alcoholism - 10 years of progress

Alcoholism: Clinical and Experimental Research

Volumn 20, Issue 8 SUPPL., 1996, Pages

  Anton, Raymond F ^a   Mann, Karl ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; NALTREXONE; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ALCOHOLISM; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SCREENING; HUMAN; PRIORITY JOURNAL; PSYCHOTHERAPY;

EID: 0029838011     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1996.tb01770.x     Document Type: Conference Paper

References (15)

1. Fuller RK, Branchey L, Brightwell DR, Derman RM, Emrick CD, Iber FL, James KE, Lacoursiere RB, Lee KK, Lowenstam I, Maany I, Neiderhiser D, Nocks JJ, Shaw S: Disulfiram treatment of alcoholism. JAMA 256:1449-1489, 1986.
2. Dorus W, Ostrow DG, Anton R, Cushman P, Collins JF, Schaefer M, Charles HL, Desai P, Hayashida M, Malkemeker U, Willenbring M, Fiscella R, Sather MR: Lithium treatment of depressed and nondepressed alcoholics. JAMA 262:1646-1652, 1989
3. Naranjo CA, Bremner KE: Evaluation of the effects of serotonin uptake inhibitors in alcoholics: A review, in Naranjo CA, Sellers EM (eds): Novel Pharmacological Interventions for Alcoholism. New York, Springer-Verlag, 1992, p 105
4. Sellers EM, Toneatto T, Romach, MK, Somer GR, Sobell, LC, Sobell MB: Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence. Alcohol din Exp Res 18:879-885, 1994
5. Le AD, Poulos CS, Quan B, Chow S: The effects of selective blockade of delta and mu opiate receptors on ethanol consumption by C57BL/6 mice in a restricted access paradigm. Brain Res 630:330-332, 1993
6. Kranzler HR, Burleson JA, Del Boca FK, Babor TF, Korner P, Brown J, Bohn MJ: Buspirone treatment of anxious-alcoholics: A placebo-controlled trial. Arch Gen Psychiatry 51:720-731, 1994
7. Malcolm R, Anton RF, Randall CL, Johnston A, Brady K, Thevos A: A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res 16:1007-1013, 1992
8. Kranzler HR, Burlson JA, Korner P, Del Boca FK, Bonn MJ, Brown J, Liebowitz N: Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry 152:391-397, 1995
9. Babor TF, Hofmann M, Del Boca FK, Hesselbrock V, Meyer RE, Dolinsky ZS, Rounsaville B: Types of alcoholics: I: Evidence for an empirically-derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry 49:599-608, 1992.
10. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP: Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880, 1992
11. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B: Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry 49:881-887, 1992.
12. O'Malley SS, Jaffe AJ, Chang G, Rode S, Schottenfeld R, Meyer RE, Rounsaville B: Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch Gen Psychiatry 53:217-224, 1996
13. Sass H, Soyka M, Mann K, Zieglgansberger W: Relapse prevention of acamprosate: Results from a placebo-controlled study in alcohol dependence. Arch Gen Psychiatry (in press)
14. Anton RF, Kranzler HR, Meyer RE: Neurobehavioral aspects of the pharmacotherapy of alcohol dependence. Clin Neurosci 3:145-154, 1995
15. Kranzler HR, Mason BJ, Pettinati HM, Anton RF: Methodological issues in pharmacotherapy trials in alcoholics, in Hertzman M, Feltner D (eds): Clinical Trials of CNS Drugs. New York, New York University Press (in press)